Published on:

Research suggests DOD medical policy malpractice, a New York Injury Lawyer says


Research into medical practices for Guantanamo detainees calls giving every detainee mefloquine, anti-malaria treatment, is malpractice. Medical experts with Seton Hall University studied the Defense Department’s policy on giving detainees large doses of the anti-malaria drug, a New York Injury Lawyer stated.

When every detainee is processed into the prison, they are administered 1,250 mg of mefloquine in two doses over a 12-hour period. Mefloquine is usually given as a lost restore to individuals who are known to have malaria. The prison does not conduct a blood test before giving the drug.

Mefloquine is known to have severe side effects including “anxiety, paranoia, hallucinations, aggression, psychotic behavior, mood changes, depression, memory impairment, convulsions, loss of coordination, suicidal ideation, and possibly suicide, particularly in patients with a history of mental illness,” the study stated.

A statement from a Defense Department representative stated that there have been only three cases of detainees coming to the facility with malaria symptoms. The facility has been in use since 2001. There are more than 700 prisoners at the facility.

Malaria is an extremely deadly disease that can kill in 48 hours. According to World Health Organization, around 1 million people died of malaria every year. The top three locations with high malaria dead rates are Africa, Southeast Asia, and the South Pacific. Cuba has no recorded malaria threats. Many the detainees are caught in these areas.

If you or one of your loved ones is being given unneeded prescriptions, or has been the victim of medical malpractice, call Stephen Bilkis and Associates to take on their case. Our office can help you through your legal proceedings, and ensure that your rights are protected. Come in for a free consultation today.

Contact Information